3E0P705
3E0P705 — Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduce of Oth Antineoplastic into Fem Reprod, Via Opening
How 3E0P705 is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- PBody partThe specific site
- 7ApproachHow the site was reached
- 0DeviceWhat was left in place, if anything
- 5QualifierA further distinction where one applies
Codes near 3E0P705
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E0P3Q0Introduction of Autologous Fertilized Ovum into Female Reproductive, Percutaneous Approach
- 3E0P3Q1Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Percutaneous Approach
- 3E0P3SFIntroduction of Other Gas into Female Reproductive, Percutaneous Approach
- 3E0P3TZIntroduction of Destructive Agent into Female Reproductive, Percutaneous Approach
- 3E0P3VZIntroduction of Hormone into Female Reproductive, Percutaneous Approach
- 3E0P45ZIntroduction of Adhesion Barrier into Female Reproductive, Percutaneous Endoscopic Approach
- 3E0P4GCIntroduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Endoscopic Approach
- 3E0P704Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening
- 3E0P705Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening
- 3E0P70MIntroduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening
- 3E0P728Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening
- 3E0P729Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening
- 3E0P73ZIntroduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening
- 3E0P76ZIntroduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening
- 3E0P77ZIntroduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening
- 3E0P7BZIntroduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening
- 3E0P7GCIntroduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening